I. Isakov, V. Čabarkapa, Branislava Srdjenovic-Conic, N. Kladar, B. Ilinčić, D. Burić
{"title":"Status of tryptophan metabolites in different stages of chronic kidney disease of non-diabetc etiology","authors":"I. Isakov, V. Čabarkapa, Branislava Srdjenovic-Conic, N. Kladar, B. Ilinčić, D. Burić","doi":"10.2298/mpns2202005i","DOIUrl":null,"url":null,"abstract":"Introduction. Modification of tryptophan metabolism during the progression of chronic kidney disease may have significant pathophysiological consequences. The aim of this study was to investigate the status of metabolic products of tryptophan, indoxyl sulfate and kynurenine in different stages of chronic kidney disease. Material and Methods. In all participants included in the cross-sectional study (n = 66) with previously diagnosed chronic kidney disease, the parameters of renal function were measured: glomerular filtration rate using radionuclide plasma clearance with 99mTc-labelled diethylene triamine penta-acetate and effective renal plasma flow using 131Ilabeled orthoiodohippuric acid. Plasma concentrations of indoxyl sulfate and kynurenine were measured by high-performance liquid chromatography. Results. A significant difference was observed in the concentrations of both metabolites between the observed groups (Group II - measured glomerular filtration rate - 15 - 60 ml/min/1.73 m?; n = 36 vs. Group I measured glomerular filtration rate > 60 l/ min/1.73 m?; n = 26): indoxyl sulfate 1.07 ? 0.89 vs. 2.44 ? 4.05 ?g/ ml, p < 0.001; kynurenine 3.15 ? 0.22 vs. 3.21 ? 0.17 ?g/ml, p < 0.05. The correlation was statistically significant between glomerular filtration rate and kynurenine - r = -0.38, p = 0.001 and indoxyl sulfate - r = 0.56, p ? 0.001; effective plasma renal flow and kynurenine - r = -0.33, p < 0.05 and indoxyl sulfate - r = 0.46, p ? 0.001. Conclusion. There is a significant difference in the plasma concentrations of indoxyl sulfate and kynurenine in the group of patients with glomerular filtration rate of 15 - 60 ml/min/1.73 m? compared to patients with glomerular filtration rate > 60 ml/min/1.73 m?. In patients with chronic kidney disease, plasma concentrations of both metabolites of tryptophan are inversely correlated with the glomerular filtration rate and effective plasma renal flow.","PeriodicalId":87940,"journal":{"name":"Calcutta medical review","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Calcutta medical review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/mpns2202005i","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction. Modification of tryptophan metabolism during the progression of chronic kidney disease may have significant pathophysiological consequences. The aim of this study was to investigate the status of metabolic products of tryptophan, indoxyl sulfate and kynurenine in different stages of chronic kidney disease. Material and Methods. In all participants included in the cross-sectional study (n = 66) with previously diagnosed chronic kidney disease, the parameters of renal function were measured: glomerular filtration rate using radionuclide plasma clearance with 99mTc-labelled diethylene triamine penta-acetate and effective renal plasma flow using 131Ilabeled orthoiodohippuric acid. Plasma concentrations of indoxyl sulfate and kynurenine were measured by high-performance liquid chromatography. Results. A significant difference was observed in the concentrations of both metabolites between the observed groups (Group II - measured glomerular filtration rate - 15 - 60 ml/min/1.73 m?; n = 36 vs. Group I measured glomerular filtration rate > 60 l/ min/1.73 m?; n = 26): indoxyl sulfate 1.07 ? 0.89 vs. 2.44 ? 4.05 ?g/ ml, p < 0.001; kynurenine 3.15 ? 0.22 vs. 3.21 ? 0.17 ?g/ml, p < 0.05. The correlation was statistically significant between glomerular filtration rate and kynurenine - r = -0.38, p = 0.001 and indoxyl sulfate - r = 0.56, p ? 0.001; effective plasma renal flow and kynurenine - r = -0.33, p < 0.05 and indoxyl sulfate - r = 0.46, p ? 0.001. Conclusion. There is a significant difference in the plasma concentrations of indoxyl sulfate and kynurenine in the group of patients with glomerular filtration rate of 15 - 60 ml/min/1.73 m? compared to patients with glomerular filtration rate > 60 ml/min/1.73 m?. In patients with chronic kidney disease, plasma concentrations of both metabolites of tryptophan are inversely correlated with the glomerular filtration rate and effective plasma renal flow.
介绍。慢性肾脏疾病进展过程中色氨酸代谢的改变可能具有显著的病理生理后果。本研究旨在探讨色氨酸、硫酸吲哚酚和犬尿氨酸在慢性肾脏疾病不同阶段的代谢产物状态。材料和方法。在横断研究中纳入的所有先前诊断为慢性肾脏疾病的参与者(n = 66)中,测量了肾功能参数:使用99mtc标记的放射性核素血浆清除率(肾小球滤过率)和使用131il标记的正碘马尿酸测量有效肾血浆流量。采用高效液相色谱法测定硫酸吲哚酚和犬尿氨酸的血药浓度。结果。观察组之间两种代谢物的浓度有显著差异(II组-测量肾小球滤过率- 15 - 60 ml/min/1.73 m?;n = 36 vs. I组肾小球滤过率> 60 l/ min/1.73 m?N = 26):硫酸吲哚酚1.07 ?0.89 vs 2.44 ?4.05 g/ ml, p < 0.001;犬尿素3.15 ?0.22 vs. 3.21 ?0.17 g/ml, p < 0.05。肾小球滤过率与犬尿氨酸- r = -0.38, p = 0.001,硫酸吲哚酚- r = 0.56, p ?0.001;有效血浆肾流量和犬尿氨酸- r = -0.33, p < 0.05,硫酸吲哚酚- r = 0.46, p ?0.001. 结论。在肾小球滤过率为15 ~ 60ml /min/1.73 m?与肾小球滤过率> 60 ml/min/1.73 m?在慢性肾病患者中,色氨酸两种代谢物的血浆浓度与肾小球滤过率和有效血浆肾流量呈负相关。